Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)

NCT05612191 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Sarcoma,Soft Tissue
Gynecologic Cancer

Interventions

DRUG: AL3818

Sponsor

Advenchen Laboratories, LLC